ABT vs NP · P/E 25, rev $44.33B vs rev $44.4M
Abbott Laboratories (ABT) versus Neptune Insurance Holdings Inc. (NP) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Neptune Insurance Holdings Inc. (NP) is a insurance brokers company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported NP revenue for 2025-09-30 was $44.4M. Net income was $11.5M. Revenue was up 31.2% from 2024-09-30 to 2025-09-30. NP currently screens at market cap $3.81B.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. NP currently screens at market cap $3.81B.
Not investment advice. Open the ABT and NP stock pages for the full models.
Not investment advice.